ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36980680

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.

Motta JM and 2 others. Cancers (Basel), 2023. Cited by 21 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma. Papers, record 36980680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980680

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
2.53
iCite
Revised in PubMed
2023-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Motta JMJuliana Mariahttps://orcid.org/0000-0001-6687-6222
2Hassan HHebatallah
3Ibrahim SASherif Abdelazizhttps://orcid.org/0000-0001-6403-7345

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References191

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,117,401Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment.Front Immunol2020https://conductscience.org/library/papers/33117401PubMed
220,229,236Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner.Cell Mol Life Sci2010https://conductscience.org/library/papers/20229236PubMed
39,391,086Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9391086PubMed
423,430,739Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes.J Biol Chem2013https://conductscience.org/library/papers/23430739PubMed
52,007,184Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.Cell Regul1991https://conductscience.org/library/papers/2007184PubMed
626,476,401Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules.Toxicol Lett2016https://conductscience.org/library/papers/26476401PubMed
725,168,226MicroRNA regulation of proteoglycan function in cancer.FEBS J2014https://conductscience.org/library/papers/25168226PubMed
822,214,534Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.EJNMMI Res2011https://conductscience.org/library/papers/22214534PubMed
93,664,507Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.Cancer Res1987https://conductscience.org/library/papers/3664507PubMed
1011,786,412Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.Am J Pathol2002https://conductscience.org/library/papers/11786412PubMed

1 to 10 of 191

See all 191 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42,589,604Myofibroblastic CAF and Malignant Ductal Cell Crosstalk Drives Epithelial-Mesenchymal Transition and Progression in Pancreatic Ductal Adenocarcinoma via THBS2-SDC/Integrin Axes.Int J Mol Sci2026https://conductscience.org/library/papers/42589604PubMed
42,374,606SDC1 Knockdown Suppresses Malignant Phenotypes of Breast Cancer by Modulating the MAPK Signaling Pathway.Cancer Med2026https://conductscience.org/library/papers/42374606PubMed
42,279,373Integrating Extracellular Matrix Dynamics and Membrane-Associated Signaling: The Role of Clusterin-LRP1 Network in Cancer Cell Migration and Tumor Progression.Cancers (Basel)2026https://conductscience.org/library/papers/42279373PubMed
42,215,496Syndecan-4 in microglia mediates ischemic stroke-induced mitochondrial dysfunction and blood-brain barrier damage by interacting with Dishevelled.Sci Rep2026https://conductscience.org/library/papers/42215496PubMed
42,085,441Plasma small-extracellular vesicles' proteomic signature in neoadjuvant chemotherapy-naïve breast cancer patients.PLoS One2026https://conductscience.org/library/papers/42085441PubMed
41,501,529Advancing spatial cellular communication inference with ligand diffusion and transport model.Commun Biol2026https://conductscience.org/library/papers/41501529PubMed
41,228,316Spheroid-Based 3D Models to Decode Cell Function and Matrix Effectors in Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41228316PubMed
41,226,609Spatial and Functional Roles of Syndecans in Skin Wound Healing.Int J Mol Sci2025https://conductscience.org/library/papers/41226609PubMed
41,148,827The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer Pathophysiology.Cells2025https://conductscience.org/library/papers/41148827PubMed
40,940,401SDC2 and FN as cargo proteins in circulating extracellular vesicles in obese breast cancer patients with lymph node metastasis.Sci Rep2025https://conductscience.org/library/papers/40940401PubMed

1 to 10 of 19

See all 19 cited by

Genes77

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ACTA158PubTator's text mininghttps://conductscience.org/library/genes/58NCBI Gene
ADAM176,868PubTator's text mininghttps://conductscience.org/library/genes/6868NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ARF6382PubTator's text mininghttps://conductscience.org/library/genes/382NCBI Gene
CCL56,352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD24100,133,941PubTator's text mininghttps://conductscience.org/library/genes/100133941NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene

1 to 10 of 77

See all 77 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980680

GET https://conductscience.org/api/papers/v1/36980680/references?page=2

API referenceFor AI assistants